14 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
assessment and oversight are an integral part of our governance and management processes. Our Board encourages management to promote a culture
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
manage our growth, including our ability to retain and recruit personnel, and maintain our culture;
ii
Table of Contents
the scope of protection we … existing operations and company culture. We cannot be certain that, following a strategic transaction or license, we will achieve the results, revenue
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
culture that facilitates the transfer of institutional knowledge within our organization and fosters innovation, teamwork, and a focus on execution … if we are unable to successfully integrate them with our existing operations and company culture. We cannot be certain that, following a strategic
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
in maintaining our corporate culture that facilitates the transfer of institutional knowledge within our organization and fosters innovation, teamwork … of such transactions if we are unable to successfully integrate them with our existing operations and company culture. We cannot be certain that, following
S-1
r5w1vl
25 Aug 23
IPO registration
5:03pm
DRS/A
73xd924sr
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
tttg3 uhhbyu0ave
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
hk4vz wjqp
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
v59vyzp
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
ipea4k2odfqygzj
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
gf9q4wh7f7k alpw4
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
e8t3z3gfmya
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
tcd5kme 8l5
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next